Using ApoE(–/–) mouse model, it was shown that over-expression of SAA3 results in a 4-fold increase in atherosclerosis lesion size over control while knockdown of SAA3 decreases atherosclerosis (Johnson et al., 2004), implying that this gene may be a new therapeutic target for atherosclerosis. The gene discussed is APOE; the disease is atherosclerosis.